Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24604347 | 0.94 | CNR2 (0.37) | CNR2DRD2MAOA | |
| SCHEMBL23096223 | 0.90 | CNR2 (0.36) | CNR2DRD2MAOACDC14BCDC14A | |
| SCHEMBL19770518 | 0.84 | CDC14B (0.44) | CNR2DRD2MAOACDC14BCDC14A | |
| SCHEMBL21331558 | 0.79 | AHR (0.44) | CNR2DRD2MAOAALDH1A1LMNA | |
| SCHEMBL18117640 | 0.79 | MAOA (0.51) | CNR2MAOAALDH1A1LMNAKDM4E | |
| SCHEMBL19770522 | 0.79 | CNR2 (0.41) | CNR2DRD2MAOAALDH1A1LMNA | |
| SCHEMBL29467235 | 0.77 | CNR2 (0.42) | CNR2ALDH1A1KDM4E | |
| SCHEMBL26389769 | 0.77 | CNR2 (0.42) | CNR2ALDH1A1KDM4E | |
| SCHEMBL18795081 | 0.77 | CDC14B (0.46) | CNR2DRD2MAOACDC14BCDC14A | |
| SCHEMBL22947730 | 0.76 | ALDH1A1 (0.33) | CNR2MAOACDC14BCDC14AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240023359-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| EP-4253371-A1 | NOVEL ORGANIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC Co., Ltd. (KR) | 2023-10-04 | — | — | EP | disclosed |
| US-20230183200-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-06-15 | — | — | US | disclosed |
| US-11482676-B2 | Light emitting diode including boron compound | SFC CO., LTD. (KR) | 2022-10-25 | — | — | US | disclosed |
| US-20220216431-A1 | COMPOUND FOR ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | SFC CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
| US-20220123219-A1 | COMPOUND FOR ORGANIC LIGHT EMITTING ELEMENT, AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME AND HAVING LONG LIFESPAN | SFC CO., LTD. (KR) | 2022-04-21 | — | — | US | disclosed |
| US-20210036233-A1 | LIGHT EMITTING DIODE INCLUDING BORON COMPOUND | SFC CO., LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183200-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | TRPA1, CRY2, SUN2 | CNR2 1597/4885DRD2 179/4885MAOA 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.